S&P 500   3,826.51 (-1.13%)
DOW   31,316.84 (-0.24%)
QQQ   310.08 (-2.61%)
AAPL   122.51 (-2.09%)
MSFT   227.49 (-2.73%)
FB   256.26 (-1.06%)
GOOGL   2,019.37 (-2.19%)
TSLA   655.18 (-4.55%)
AMZN   3,013.30 (-2.62%)
NVDA   514.36 (-4.08%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.94 (-1.26%)
NIO   41.23 (-4.76%)
AMD   81.34 (-3.32%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.69 (-4.59%)
PFE   34.34 (+2.48%)
S&P 500   3,826.51 (-1.13%)
DOW   31,316.84 (-0.24%)
QQQ   310.08 (-2.61%)
AAPL   122.51 (-2.09%)
MSFT   227.49 (-2.73%)
FB   256.26 (-1.06%)
GOOGL   2,019.37 (-2.19%)
TSLA   655.18 (-4.55%)
AMZN   3,013.30 (-2.62%)
NVDA   514.36 (-4.08%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.94 (-1.26%)
NIO   41.23 (-4.76%)
AMD   81.34 (-3.32%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.69 (-4.59%)
PFE   34.34 (+2.48%)
S&P 500   3,826.51 (-1.13%)
DOW   31,316.84 (-0.24%)
QQQ   310.08 (-2.61%)
AAPL   122.51 (-2.09%)
MSFT   227.49 (-2.73%)
FB   256.26 (-1.06%)
GOOGL   2,019.37 (-2.19%)
TSLA   655.18 (-4.55%)
AMZN   3,013.30 (-2.62%)
NVDA   514.36 (-4.08%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.94 (-1.26%)
NIO   41.23 (-4.76%)
AMD   81.34 (-3.32%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.69 (-4.59%)
PFE   34.34 (+2.48%)
S&P 500   3,826.51 (-1.13%)
DOW   31,316.84 (-0.24%)
QQQ   310.08 (-2.61%)
AAPL   122.51 (-2.09%)
MSFT   227.49 (-2.73%)
FB   256.26 (-1.06%)
GOOGL   2,019.37 (-2.19%)
TSLA   655.18 (-4.55%)
AMZN   3,013.30 (-2.62%)
NVDA   514.36 (-4.08%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.94 (-1.26%)
NIO   41.23 (-4.76%)
AMD   81.34 (-3.32%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.69 (-4.59%)
PFE   34.34 (+2.48%)
Log in
NASDAQ:AQB

AquaBounty Technologies Stock Forecast, Price & News

$6.50
-0.89 (-12.04 %)
(As of 03/3/2021 03:46 PM ET)
Add
Compare
Today's Range
$6.46
Now: $6.50
$7.49
50-Day Range
$7.09
MA: $9.65
$12.20
52-Week Range
$1.59
Now: $6.50
$13.32
Volume101,567 shs
Average Volume3.75 million shs
Market Capitalization$457.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27
AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts.
AquaBounty Technologies logo

Headlines

Why AquaBounty Technologies Stock Plunged Today
February 4, 2021 |  finance.yahoo.com
AquaBounty Technologies Provides Corporate Update
December 9, 2020 |  finance.yahoo.com
AquaBounty Technologies, Inc. (AQB)
October 6, 2020 |  finance.yahoo.com
2 “Strong Buy” Stocks Insiders Are Snapping Up
August 17, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Fishing, hunting & trapping
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AQB
CUSIPN/A
Phone978-648-6000
Employees71
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$190,000.00
Book Value$1.10 per share

Profitability

Net Income$-13,230,000.00
Net Margins-11,050.81%

Miscellaneous

Market Cap$457.91 million
Next Earnings Date3/9/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.43 out of 5 stars

Medical Sector

535th out of 1,969 stocks

Fishing, Hunting & Trapping Industry

1st out of 5 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
$6.50
-0.89 (-12.04 %)
(As of 03/3/2021 03:46 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions

Is AquaBounty Technologies a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AquaBounty Technologies stock.
View analyst ratings for AquaBounty Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than AquaBounty Technologies?

Wall Street analysts have given AquaBounty Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AquaBounty Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AquaBounty Technologies?

AquaBounty Technologies saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 1,580,000 shares, an increase of 46.3% from the January 28th total of 1,080,000 shares. Based on an average daily trading volume, of 4,640,000 shares, the days-to-cover ratio is presently 0.3 days.
View AquaBounty Technologies' Short Interest
.

When is AquaBounty Technologies' next earnings date?

AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for AquaBounty Technologies
.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) announced its quarterly earnings data on Tuesday, November, 3rd. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.01. The firm earned $0.07 million during the quarter, compared to analyst estimates of $1.79 million. AquaBounty Technologies had a negative net margin of 11,050.81% and a negative trailing twelve-month return on equity of 36.77%.
View AquaBounty Technologies' earnings history
.

How has AquaBounty Technologies' stock price been impacted by Coronavirus (COVID-19)?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AQB shares have increased by 271.9% and is now trading at $6.88.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for AQB?

3 equities research analysts have issued 12 month price targets for AquaBounty Technologies' shares. Their forecasts range from $3.50 to $9.00. On average, they anticipate AquaBounty Technologies' stock price to reach $5.83 in the next twelve months. This suggests that the stock has a possible downside of 15.2%.
View analysts' price targets for AquaBounty Technologies
or view top-rated stocks among Wall Street analysts.

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:
  • Ms. Sylvia A. Wulf, CEO, Pres & Exec. Director (Age 63, Pay $383.17k)
  • Mr. David A. Frank, CFO & Treasurer (Age 61, Pay $282.8k)
  • Dr. Alejandro Rojas, Chief Operating Officer of AquaBounty Farms (Age 59, Pay $234.1k)
  • Dr. Mark Walton, Chief Technology Officer
  • Ms. Angela M. Olsen J.D., Gen. Counsel & Corp. Sec. (Age 52)
  • Dave Conley, Director of Communications
  • Mr. David F. Melbourne Jr., Chief Commercial Officer
  • Mr. Louis H. Barnett, Financial Advisor

Who are some of AquaBounty Technologies' key competitors?

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are AquaBounty Technologies' major shareholders?

AquaBounty Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Third Security LLC (25.86%), Epiq Partners LLC (1.46%), Sumitomo Mitsui Trust Holdings Inc. (0.35%), Nikko Asset Management Americas Inc. (0.28%), Capital Impact Advisors LLC (0.27%) and Voloridge Investment Management LLC (0.10%). Company insiders that own AquaBounty Technologies stock include David A Frank, Randal J Kirk, Richard L Huber and Rick L Sterling.
View institutional ownership trends for AquaBounty Technologies
.

Which institutional investors are selling AquaBounty Technologies stock?

AQB stock was sold by a variety of institutional investors in the last quarter, including HighTower Advisors LLC, Epiq Partners LLC, Third Security LLC, Winthrop Advisory Group LLC, Cambridge Investment Research Advisors Inc., and KBC Group NV.
View insider buying and selling activity for AquaBounty Technologies
or view top insider-selling stocks.

Which institutional investors are buying AquaBounty Technologies stock?

AQB stock was acquired by a variety of institutional investors in the last quarter, including Capital Impact Advisors LLC, Voloridge Investment Management LLC, Price T Rowe Associates Inc. MD, Citigroup Inc., Bank of New York Mellon Corp, Exencial Wealth Advisors LLC, Wells Fargo & Company MN, and Nikko Asset Management Americas Inc.. Company insiders that have bought AquaBounty Technologies stock in the last two years include David A Frank, Randal J Kirk, Richard L Huber, and Rick L Sterling.
View insider buying and selling activity for AquaBounty Technologies
or or view top insider-buying stocks.

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $6.88.

How much money does AquaBounty Technologies make?

AquaBounty Technologies has a market capitalization of $484.68 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis.

How many employees does AquaBounty Technologies have?

AquaBounty Technologies employs 71 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is www.aquabounty.com.

Where are AquaBounty Technologies' headquarters?

AquaBounty Technologies is headquartered at 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.